COVID-19 a complex multi-organ disease requires comprehensive diagnostic solutions

HUMAN supports laboratories with comprehensive solutions for the diagnosis of a wide range of aspects of COVID-19. For triage of SARS-CoV-2 patients, parameters of hematology and clinical chemistry are recommended. Coagulation parameters provide information on the prognosis of the patients. 

Since the beginning of the COVID-19 pandemic, laboratories have been using nucleic acid amplification tests, such as RT-PCR. In many countries, access to this form of testing is still challenging. Therefore, rapid antigen tests are important as they are close to the patient and relatively easy to use. HUMAN has found reliable partners and manufacturers of SARS-CoV-2 antigen rapid tests and is now ready to provide you with these tests.

Antigen Rapid Test - For the qualitative detection of SARS-CoV-2 antigen

COVID-19 related diagnostic solutions

Genetic characteristics influence susceptibility to COVID-19 Blood group A a risk factor for COVID-19?

The rapid global spread of the noval SARS-CoV-2 virus is straining existing health resources, so identifying infected persons and prioritising people at high risk has become a critical challenge.

Click here to read more

Publication about COVID-19 Kidney disease

An early warning for severity and complications
Several publications indicate that the novel coronavirus SARS-CoV-2 does not only affect the lungs but also impacts numerous other organs, like kidneys which have been observed to be the second most frequently affected organs.

Click here to read more

Main laboratory abnormalities associated with COVID-19

Although RT-PCR is the recommended testing for diagnosis of a SARS-CoV-2 infection, there are numerous other diagnostic parameters that show abnormal laboratory results in COVID-19 patients. 

Click here to read more

Enhancing the expeditious triage of COVID-19 patients through the utilization of hematology and CRP

In many countries, health organizations fear that they will find themselves in a situation where too many patients seek help in clinics, similar to the COVID 19 outbreak in Wuhan/China.

Click here to read more

ISTH interim guidance on recognition and management of coagulopathy in COVID-19

According to recent observations, coagulopathy often occurs in severe cases of COVID-19 patients. Coagulopathy is a condition in which the ability of the blood to clot is impaired - a term that includes the thrombotic state in sepsis.

Click here to read more

Webinars on demand

Autoantibodies in COVID and Long-COVID - more cases of thrombosis and autoimmune disease on the horizon?

Since 2020 the corona virus keeps changing the world. But not only the mutations of the virus and the disease itself, but also lasting complications, such as long COVID are a topic of concern. As recent studies show, raised levels of autoantibodies, that are associated to COVID-19 can lead to the development of various autoimmune reactions and diseases. In this webinar we will have a spotlight on autoantibodies that specifically trigger platelet activation.

Click here to watch the webinar


SARS-CoV-2 antibody testing - the when, the what and the how

Learn about when antibody testing is most valuable, what you have to consider when choosing a test and how HUMAN provides solutions. Discuss the RDT and ELISA solutions provided by HUMAN with our experts.

Click here to watch the webinar





Supporting faster triage of COVID-19 patients through the use of hematology and the role of blood groups in SARS-CoV-2 infection

Get an overview on strategies of fast decision makings on COVID-19 patients and learn about blood groups as a risk factor for a severe progress of the disease. Use the chance to exchange ideas with our product specialists in hematology and blood grouping.

Click here to watch the webinar


Thromboinflammation in COVID-19: the importance of D-dimer and coagulation assays

Thrombotic and inflammatory events both contribute to acute organ damage in thromboinflammation, which is a  typical  characteristic of a severe course of COVID-19. 

Click here to watch the webinar



Supporting faster triage of COVID-19 patients by the use of hematology and CRP

Learn more about the clinical and technical background also regarding COVID-19 for this very interesting win-win relationship and discuss with our specialists for hematology and COVID-19.

Click here to watch the webinar



The importance of D-dimer and other Hemostasis parameters in COVID-19 patients

Learn more about the clinical background regarding the importance of D-dimer and other Hemostasis parameters

Click here to watch the webinar



COVID-19 Publication List

This document contains a selection of relevant scientific publications related to COVID-19.The content has been compiled to the best of our knowledge and belief and makes no claim to completeness or correctness.

Click here to read more

Interim Guidance on the Use of Rapid Antigen Tests for COVID-19 Response

This document provides guidance to Ministries of Health (MOHs), laboratorypersonnel and implementing partners in African Union Member States on theapplication of rapid antigen tests to COVID-19 testing.

Click here to read more